Sarah Lunardi

Azienda Ospedaliero-Universitaria Careggi

Papers

1

Total Citations

8

H-Index

1

About

Dr. Sarah Lunardi is a leading interventional radiologist whose work centers on advancing minimally invasive, image-guided techniques for cancer treatment, particularly in hepatobiliary oncology. Her primary research focuses on optimizing stereotactic body radiation therapy (SBRT) for liver tumors, a field where precise tumor targeting is critical. Dr. Lunardi’s most cited study, a 2017 prospective trial, provides a pivotal comparative analysis of three different fiducial markers and needles used for percutaneous ultrasound-guided placement prior to robotic SBRT. This work systematically evaluated the feasibility, safety, and technical nuances of each approach, offering clinicians a practical, evidence-based framework to improve procedural accuracy and patient outcomes. By demonstrating that ultrasound guidance is a reliable method for marker placement, her research directly enhances the efficacy of non-surgical liver cancer treatments. With her work accumulating citations and informing best practices, Dr. Lunardi has established herself as a key contributor to the evolution of interventional oncology, bridging the gap between radiology and radiation therapy to deliver more precise, life-saving care.

Research Focus

Key Achievements

1
H-Index
1
Papers
8
Total Citations
8
Avg Citations/Paper
🏆 Most Cited Paper
Percutaneous ultrasound-guided fiducial marker placement for liver cancer robotic stereotactic radio-surgery treatment: A comparative analysis of three types of markers and needles
8 citations · 2017
📈 Most Prolific Year: 2017 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: Azienda Ospedaliero-Universitaria Careggi

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago